[Autoimmune hepatitis and overlap syndrome: diagnosis]

Area of Science:

• Hepatology
• Immunology
• Autoimmune Diseases

Context:

• Autoimmune hepatitis (AIH) is a rare chronic liver disorder affecting approximately 5% of patients with chronic liver disease.
• AIH is characterized by a loss of immune tolerance to hepatic proteins, leading to inflammation and liver damage.
• The disease exhibits a female predominance and is often associated with hypergammaglobulinemia and extrahepatic autoimmune conditions.

Purpose:

• To delineate the distinct subtypes of autoimmune hepatitis (AIH) based on serological markers.
• To clarify the diagnostic criteria for AIH types 1, 2, and 3, including associated autoantibodies like ANA, SMA, LKM-1, and SLA/LP.
• To explain the concept and diagnostic features of overlap syndromes between AIH and other autoimmune liver diseases, such as primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC).

Summary:

• AIH is classified into types based on autoantibody profiles: Type 1 (ANA/SMA), Type 2 (LKM-1), and Type 3 (SLA/LP).
• Antineutrophil cytoplasmic antibodies (ANCA) are associated with AIH Type 1 and primary sclerosing cholangitis (PSC), but not AIH Type 2.
• Overlap syndromes (AIH/PBC, AIH/PSC) are recognized, characterized by mixed serological and clinical features, and can be diagnosed using specific autoantibody panels and clinical findings.
• AIH can also co-occur with other organ-specific autoimmune diseases, as seen in autoimmune polyglandular syndrome type 1 (APS-1).

Impact:

• Accurate classification of AIH subtypes and recognition of overlap syndromes improve diagnostic precision.
• Understanding the specific autoantibody profiles aids in predicting disease course and response to immunosuppressive therapy.
• This knowledge facilitates tailored treatment strategies for patients with complex autoimmune liver conditions, potentially improving outcomes and reducing disease progression.